Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Encompass Health

Encompass Health (NYSE: EHC) insider transactions

In the twelve months to 10 November 2026, executives and directors of Encompass Health reported 18 open-market sales of 404,109 shares ($47.8m) and 0 open-market purchases, by 6 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Encompass Health shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
19 October 2026Reidy Christopher RDirectorGrant or award+284$126.8918,081Form 4
19 October 2026Christie Edward M IIIDirectorGrant or award+221$126.639,577Form 4
15 October 2026Katz Leslye GDirectorGrant or award+81—49,724Form 4
15 October 2026O'Connor Kevin J.DirectorGrant or award+18—11,600Form 4
15 October 2026Hayes Cain ADirectorGrant or award+4—2,100Form 4
15 October 2026Reidy Christopher RDirectorGrant or award+20—17,797Form 4
15 October 2026Christie Edward M IIIDirectorGrant or award+11—9,356Form 4
15 October 2026Herman Joan EDirectorGrant or award+81—49,724Form 4
15 October 2026Schlichting Nancy MDirectorGrant or award+38—23,010Form 4
15 October 2026Williams TerranceDirectorGrant or award+28—16,887Form 4
15 October 2026Carmichael Greg DDirectorGrant or award+28—20,377Form 4
31 August 2026Darby John PatrickEVP, Gen Counsel & SecretaryOption exercise+4,858$35.0679,899Form 4
31 August 2026Darby John PatrickEVP, Gen Counsel & SecretaryOpen-market sale−4,858$121.0975,041Form 4
31 August 2026Price Andrew LChief Accounting OfficerOpen-market sale−5,211$120.9369,483Form 4
10 August 2026Darby John PatrickEVP, Gen Counsel & SecretaryOpen-market sale−8,906$125.9575,041Form 4
10 August 2026Tarr Mark JPresident & CEOOpen-market sale−171,569$125.46269,393Form 4
10 August 2026Tarr Mark JPresident & CEOOpen-market sale−1,579$126.06267,814Form 4
10 August 2026Coltharp Douglas EEVP & Chief Financial OfficerOpen-market sale−18,869$125.3850,508Form 4
16 July 2026Christie Edward M IIIDirectorGrant or award+248$112.439,345Form 4
16 July 2026Reidy Christopher RDirectorGrant or award+319$112.4017,777Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Encompass Health page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.